METTLER-TOLEDO INTERNATIONAL (MTD) Stock Fundamental Analysis
NYSE:MTD - New York Stock Exchange, Inc. - US5926881054 - Common Stock - Currency: USD
MTD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 56 industry peers in the Life Sciences Tools & Services industry. While MTD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MTD has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
MTD had positive earnings in the past year.
MTD had a positive operating cash flow in the past year.
In the past 5 years MTD has always been profitable.
Each year in the past 5 years MTD had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 26.25%, MTD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
MTD has a better Return On Invested Capital (43.51%) than 96.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MTD is significantly above the industry average of 12.97%.
The last Return On Invested Capital (43.51%) for MTD is above the 3 year average (41.86%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.25% | ||
| ROE | N/A | ||
| ROIC | 43.51% |
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
1.3 Margins
MTD has a Profit Margin of 22.17%. This is amongst the best in the industry. MTD outperforms 100.00% of its industry peers.
MTD's Profit Margin has improved in the last couple of years.
MTD's Operating Margin of 28.85% is amongst the best of the industry. MTD outperforms 100.00% of its industry peers.
MTD's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 60.14%, MTD belongs to the best of the industry, outperforming 83.93% of the companies in the same industry.
MTD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.85% | ||
| PM (TTM) | 22.17% | ||
| GM | 60.14% |
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MTD is creating value.
Compared to 1 year ago, MTD has less shares outstanding
MTD has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MTD is higher compared to a year ago.
2.2 Solvency
MTD has an Altman-Z score of 10.25. This indicates that MTD is financially healthy and has little risk of bankruptcy at the moment.
MTD has a better Altman-Z score (10.25) than 94.64% of its industry peers.
MTD has a debt to FCF ratio of 2.39. This is a good value and a sign of high solvency as MTD would need 2.39 years to pay back of all of its debts.
The Debt to FCF ratio of MTD (2.39) is better than 83.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.39 | ||
| Altman-Z | 10.25 |
ROIC/WACC4.21
WACC10.33%
2.3 Liquidity
A Current Ratio of 1.01 indicates that MTD should not have too much problems paying its short term obligations.
MTD has a worse Current ratio (1.01) than 83.93% of its industry peers.
A Quick Ratio of 0.70 indicates that MTD may have some problems paying its short term obligations.
MTD has a worse Quick ratio (0.70) than 92.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
MTD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.69%.
MTD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.53% yearly.
Looking at the last year, MTD shows a small growth in Revenue. The Revenue has grown by 1.18% in the last year.
MTD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.18% yearly.
EPS 1Y (TTM)5.69%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%-7.87%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%-4.56%
3.2 Future
The Earnings Per Share is expected to grow by 9.11% on average over the next years. This is quite good.
MTD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.32% yearly.
EPS Next Y1.83%
EPS Next 2Y6.21%
EPS Next 3Y8.24%
EPS Next 5Y9.11%
Revenue Next Year2.22%
Revenue Next 2Y3.41%
Revenue Next 3Y3.97%
Revenue Next 5Y4.32%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 29.31, which means the current valuation is very expensive for MTD.
Compared to the rest of the industry, the Price/Earnings ratio of MTD indicates a somewhat cheap valuation: MTD is cheaper than 64.29% of the companies listed in the same industry.
MTD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 25.54, which means the current valuation is very expensive for MTD.
MTD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MTD is cheaper than 69.64% of the companies in the same industry.
MTD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.43, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.31 | ||
| Fwd PE | 25.54 |
4.2 Price Multiples
71.43% of the companies in the same industry are more expensive than MTD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, MTD is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.44 | ||
| EV/EBITDA | 21.33 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MTD may justify a higher PE ratio.
PEG (NY)16
PEG (5Y)2.34
EPS Next 2Y6.21%
EPS Next 3Y8.24%
5. Dividend
5.1 Amount
No dividends for MTD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1186
+26.9 (+2.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.77%
Inst Owner Change2.64%
Ins Owners0.41%
Ins Owner Change1.1%
Market Cap24.72B
Analysts67.37
Price Target1301.39 (9.73%)
Short Float %2.55%
Short Ratio2.61
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.86%
Min EPS beat(2)2.78%
Max EPS beat(2)4.94%
EPS beat(4)4
Avg EPS beat(4)3.62%
Min EPS beat(4)1.02%
Max EPS beat(4)5.75%
EPS beat(8)6
Avg EPS beat(8)2.82%
EPS beat(12)10
Avg EPS beat(12)2.83%
EPS beat(16)14
Avg EPS beat(16)3.44%
Revenue beat(2)1
Avg Revenue beat(2)1.19%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)2.56%
Revenue beat(4)3
Avg Revenue beat(4)0.83%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)2.56%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)8
Avg Revenue beat(12)0.26%
Revenue beat(16)12
Avg Revenue beat(16)0.79%
PT rev (1m)-8.62%
PT rev (3m)-6.48%
EPS NQ rev (1m)-6.48%
EPS NQ rev (3m)-6.87%
EPS NY rev (1m)-2.82%
EPS NY rev (3m)-2.82%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)-0.6%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.31 | ||
| Fwd PE | 25.54 | ||
| P/S | 6.45 | ||
| P/FCF | 28.44 | ||
| P/OCF | 25.41 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.33 |
EPS(TTM)40.46
EY3.41%
EPS(NY)46.43
Fwd EY3.92%
FCF(TTM)41.7
FCFY3.52%
OCF(TTM)46.68
OCFY3.94%
SpS183.79
BVpS-8.73
TBVpS-53.12
PEG (NY)16
PEG (5Y)2.34
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.25% | ||
| ROE | N/A | ||
| ROCE | 52.99% | ||
| ROIC | 43.51% | ||
| ROICexc | 44.9% | ||
| ROICexgc | 82.8% | ||
| OM | 28.85% | ||
| PM (TTM) | 22.17% | ||
| GM | 60.14% | ||
| FCFM | 22.69% |
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
ROICexc(3y)43.32%
ROICexc(5y)40.86%
ROICexgc(3y)78.59%
ROICexgc(5y)73.33%
ROCE(3y)50.98%
ROCE(5y)47.86%
ROICexcg growth 3Y5.41%
ROICexcg growth 5Y8.89%
ROICexc growth 3Y5.36%
ROICexc growth 5Y6.84%
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
F-Score7
Asset Turnover1.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.39 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 84.96% | ||
| Cap/Sales | 2.71% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.29% | ||
| Profit Quality | 102.34% | ||
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 10.25 |
F-Score7
WACC10.33%
ROIC/WACC4.21
Cap/Depr(3y)92.83%
Cap/Depr(5y)94.35%
Cap/Sales(3y)2.85%
Cap/Sales(5y)2.89%
Profit Quality(3y)97.94%
Profit Quality(5y)100.58%
High Growth Momentum
Growth
EPS 1Y (TTM)5.69%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%-7.87%
EPS Next Y1.83%
EPS Next 2Y6.21%
EPS Next 3Y8.24%
EPS Next 5Y9.11%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%-4.56%
Revenue Next Year2.22%
Revenue Next 2Y3.41%
Revenue Next 3Y3.97%
Revenue Next 5Y4.32%
EBIT growth 1Y1.9%
EBIT growth 3Y4.18%
EBIT growth 5Y8.92%
EBIT Next Year9.84%
EBIT Next 3Y8.65%
EBIT Next 5Y8.18%
FCF growth 1Y9.12%
FCF growth 3Y2.57%
FCF growth 5Y11.3%
OCF growth 1Y5.56%
OCF growth 3Y2.14%
OCF growth 5Y9.92%